Blood markers may reveal breast cancer hormone sensitivity
NCT ID NCT01612871
First seen Apr 18, 2026 · Last updated Apr 30, 2026 · Updated 4 times
Summary
This study looked at whether tiny molecules called microRNAs in the blood can help doctors know if hormone therapy will work for women with advanced breast cancer. Researchers tested blood samples from 39 women before and after starting treatment with tamoxifen or aromatase inhibitors. The goal was to see if these microRNAs could predict treatment response, which could lead to more personalized care in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centre Val d'Aurelle - Paul Lamarque
Montpellier, 34298, France
-
Institut Claudius REGAUD Toulouse
Toulouse, 31052, France
Conditions
Explore the condition pages connected to this study.